Aptose Biosciences
Toronto
About Aptose Biosciences
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $219.9M
- Funding stage: M&A
- Last round: Post-IPO Debt (Sep 2025)
- Ticker: tsx:APS
- Website: aptose.com
- Phone: 416-798-1200
Industries & Categories
Biopharma, Biotechnology, Clinical Trials
Social Profiles
Canonical: https://fsome.com/organization/aptose-biosciences-128989 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.